Related Experiment Video

Updated: Jun 20, 2026

Defining Gene Functions in Tumorigenesis by Ex vivo Ablation of Floxed Alleles in Malignant Peripheral Nerve Sheath Tumor Cells
09:37

Defining Gene Functions in Tumorigenesis by Ex vivo Ablation of Floxed Alleles in Malignant Peripheral Nerve Sheath Tumor Cells

Published on: August 25, 2021

Escape from p53-mediated tumor surveillance in neuroblastoma: switching off the p14(ARF)-MDM2-p53 axis

T Van Maerken1, J Vandesompele, A Rihani

  • 1Center for Medical Genetics, Ghent University Hospital, Ghent B-9000, Belgium. Tom.VanMaerken@UGent.be

Cell Death and Differentiation
|September 26, 2009
PubMed

Insights

Neuroblastoma tumors evade the p53 tumor suppressor

Area of Science:

  • Oncology
  • Molecular Biology
  • Genetics

Background:

  • The p53 tumor suppressor protein is crucial for preventing cancer by halting uncontrolled cell growth.
  • TP53 gene mutations are rare in neuroblastoma, indicating alternative mechanisms of p53 inactivation in this cancer.
  • Understanding how neuroblastoma bypasses p53 control is key to developing new treatments.

Purpose of the Study:

  • To review the mechanisms by which neuroblastoma cells evade p53-mediated growth control.
  • To identify the primary pathways responsible for p53 inactivation in neuroblastoma.
  • To explore potential therapeutic strategies targeting these evasion mechanisms.

Main Methods:

  • Literature review of recent studies on p53 regulation in neuroblastoma.
  • Analysis of molecular pathways involved in p53 inactivation.
  • Synthesis of findings to understand p53 evasion in neuroblastoma.

Main Results:

  • Neuroblastoma cells employ various strategies to circumvent p53's tumor-suppressive functions.
  • The p14(ARF)-MDM2-p53 signaling pathway is frequently deregulated in neuroblastoma.
  • This axis represents a critical mechanism for p53 inactivation in this pediatric cancer.

Conclusions:

  • Deregulation of the p14(ARF)-MDM2-p53 axis is the principal mechanism of p53 inactivation in neuroblastoma.
  • Targeting this axis offers promising therapeutic avenues for neuroblastoma treatment.
  • Further research into p53 regulation in neuroblastoma can lead to novel anti-cancer strategies.

More Related Videos

Yeast As a Chassis for Developing Functional Assays to Study Human P5314:57

Yeast As a Chassis for Developing Functional Assays to Study Human P53

Published on: August 4, 2019

Detection of Aggregation-Prone Behavior in Mutant P53 V157F Breast Cancer Cells Using Multipoint Thioflavin T Fluorescence04:56

Detection of Aggregation-Prone Behavior in Mutant P53 V157F Breast Cancer Cells Using Multipoint Thioflavin T Fluorescence

Published on: December 30, 2025

Related Concept Videos

Abnormal Proliferation02:23

Abnormal Proliferation

Under normal conditions, most adult cells remain in a non-proliferative state unless stimulated by internal or external factors to replace lost cells. Abnormal cell proliferation is a condition in which the cell's growth exceeds and is uncoordinated with normal cells. In such situations, cell division persists in the same excessive manner even after cessation of the stimuli, leading to persistent tumors. The tumor arises from the damaged cells that replicate to pass the damage to the daughter...
Negative Regulator Molecules01:23

Negative Regulator Molecules

Positive regulators allow a cell to advance through cell cycle checkpoints. Negative regulators have an equally important role as they terminate a cell’s progression through the cell cycle—or pause it—until the cell meets specific criteria.
DNA Damage can Stall the Cell Cycle02:36

DNA Damage can Stall the Cell Cycle

In response to DNA damage, cells can pause the cell cycle to assess and repair the breaks. However, the cell must check the DNA at certain critical stages during the cell cycle. If the cell cycle pauses before DNA replication, the cells will contain twice the amount of DNA. On the other hand, if cells arrest after DNA replication but before mitosis, they will contain four times the normal amount of DNA. With a host of specialized proteins at their disposal,cells must use the right protein at...
DNA Damage Can Stall the Cell Cycle02:36

DNA Damage Can Stall the Cell Cycle

In response to DNA damage, cells can pause the cell cycle to assess and repair the breaks. However, the cell must check the DNA at certain critical stages during the cell cycle. If the cell cycle pauses before DNA replication, the cells will contain twice the amount of DNA. On the other hand, if cells arrest after DNA replication but before mitosis, they will contain four times the normal amount of DNA. With a host of specialized proteins at their disposal,cells must use the right protein at...
Interactions Between Signaling Pathways01:19

Interactions Between Signaling Pathways

Signaling cascades usually lack linearity. Multiple pathways interact and regulate one another, allowing cells to integrate and respond to diverse environmental stimuli.
Convergence and divergence, and cross-talk between signaling pathways
Two distinct signaling pathways can converge on a single functional unit, which may either be a single protein or a complex of proteins. The response is either functionally distinct or synergistic between the two pathways but different from the response...
The Intrinsic Apoptotic Pathway01:31

The Intrinsic Apoptotic Pathway

Internal cellular stress, such as cellular injury or hypoxia, triggers intrinsic apoptosis. The B-cell lymphoma 2 (Bcl-2) family of proteins are the primary regulators of the intrinsic apoptotic pathway. For example, during DNA damage, checkpoint proteins, such as Ataxia Telangiectasia Mutated (ATM protein) and Checkpoints Factor-2 (Chk2) proteins, are activated. These proteins phosphorylate p53 which further activates pro-apoptotic proteins, such as Bax, Bak, PUMA, and Noxa, and inhibits...